Corpus ID: 17957562

Apolipoprotein B ( ApoB ) and apolipoprotein A 1 The Apolipoprotein B / A 1 Ratio is Associated with Reactive Oxygen Metabolites and Endothelial Dysfunction in Statin-Treated Patients with Coronary Artery Disease

@inproceedings{Emoto2013ApolipoproteinB,
  title={Apolipoprotein B ( ApoB ) and apolipoprotein A 1 The Apolipoprotein B / A 1 Ratio is Associated with Reactive Oxygen Metabolites and Endothelial Dysfunction in Statin-Treated Patients with Coronary Artery Disease},
  author={Takuo Emoto and Takahiro Sawada and Natsumi Morimoto and T. Tenjin and T. Wakimoto and F. Ikeda and C. Sato and Daisuke Terashita and T. Mizoguchi and Takao Mizuguchi and H. Okamoto and Yosuke Matsuo and Sushi-ku Kim and A. Takarada and M. Yokoyama},
  year={2013}
}
  • Takuo Emoto, Takahiro Sawada, +12 authors M. Yokoyama
  • Published 2013
  • There is convincing evidence that statin treatment significantly reduces the risk of cardiac events in patients with dyslipidemia . The administration of statins is strongly recommended for the primary and secondary prevention of coronary artery disease (CAD). Specifically, the American Heart Association and American College of Cardiology Foundation (AHA/ ACCF) guidelines set the goal of statin treatment for the secondary prevention of CAD in patients with low density lipoprotein (LDL… CONTINUE READING

    Tables from this paper

    References

    SHOWING 1-10 OF 24 REFERENCES